(Q48592475)

13 February 2018

title

Insight, neurocognitive function and symptom clusters in chronic schizophrenia (English)

1 reference

13 February 2018

0 references

A A Collins

1

1 reference

13 February 2018

G J Remington

series ordinal

2

1 reference

13 February 2018

K Coulter

series ordinal

3

1 reference

13 February 2018

K Birkett

series ordinal

4

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

13 February 2018

published in

Schizophrenia Research

1 reference

13 February 2018

volume

27

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

37-44

1 reference

13 February 2018

A depression rating scale for schizophrenics

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Awareness of illness in schizophrenia and schizoaffective and mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Poor insight in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Awareness of illness in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Negative v positive schizophrenia. Definition and validation.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Clinical symptomatology and drug compliance in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Neuroleptic responsivity of negative and positive symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Depression in schizophrenia: a comparison of three measures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Molecular pathology of schizophrenia: more than one disease process?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

The two-syndrome concept: origins and current status

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Lack of insight: Its status within schizophrenic psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Insight and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

The assessment of insight in psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Psychotherapy of schizophrenia: an empirical investigation of the relationship of process to outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Performance of schizophrenic patients on putative neuropsychological tests of frontal lobe function.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Probing prefrontal function in schizophrenia with neuropsychological paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Insight and interpretation of illness in recovery from psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Effects of Psychotherapy in Schizophrenia: II. Comparative Outcome of Two Forms of Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Early insight and the management of schizophrenic decompensation.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Significance of the positive-negative distinction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Cognitive impairment in schizophrenia: Specific relations to ventricular size and negative symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Psychological predictors of insight and compliance in psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Insight in schizophrenia and its relationship to psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Depressive and negative symptoms in major psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Frontal lobe dysfunctions in schizophrenia—I. Eye movement impairments

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Frontal lobe dysfunctions in schizophrenia--II. Impairments of psychological and brain functions

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Schizophrenic syndromes, cognitive performance and neurological dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Patterns of cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Schizophrenic syndromes and frontal lobe performance

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Insight and cognitive impairment in schizophrenia. Performance on repeated administrations of the Wisconsin Card Sorting Test.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

The Meaning of Insight in Clinical Psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

The deficit state in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Insight and the clinical outcome of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Common sense, insight, and neuropsychological test performance in schizophrenia patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Unawareness of deficits in neuropsychological syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

The Mechanism of Action of Novel Antipsychotic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Neurological signs and the positive-negative dimension in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Insight in schizophrenia and mood disorders and its relation to psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Negative symptoms in schizophrenia: their longitudinal course and prognostic importance

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Insight and Hospital Adjustment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Positive and negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Visual evoked potential correlates of positive/negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Slow potential correlates of frontal function, psychosis, and negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Hypofrontality in schizophrenia: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Psychological, topographic EEG, and CT scan correlates of frontal lobe function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Correlation of negative symptoms in schizophrenia with frontal lobe parameters on magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Unawareness of illness and neuropsychological performance in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

Contributions of clinical neuropsychology to the study of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900075-3

7 January 2021

10.1016/S0920-9964(97)00075-3

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018